The Miami Project faculty is a multidisciplinary team comprised of both basic and clinical scientists with expertise in neuroscience.
Read a Message from the Scientific Director, W. Dalton Dietrich, Ph.D.
SHOP OUR eBAY STORE TODAY!
Do you have an upcoming birthday gift or holiday gift to purchase? We have you covered!!!
Shop in our eBay store today and give back to charity! Buy items ranging from autographed sports memorabilia, baby gifts, accessories, home items, kidz korner, logo'd merchandise and much more!!
Our broad scope of collaborative research is dedicated to finding new treatments for spinal cord injury.
Read a Message from the Chairman, Barth A. Green, M.D.
Doctors at The Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine, performed the first-ever Food and Drug Administration approved Schwann cell transplantation in a patient with a new spinal cord injury. The procedure, performed at the University of Miami/Jackson Memorial Medical Center, is a Phase 1 clinical trial designed to evaluate the safety and feasibility of transplanting the patient’s own Schwann cells.
“This historic clinical trial represents a giant step forward in a field of medicine where each tangible step has tremendous value. This trial, and these first patients in this trial specifically, are extremely important to our mission of curing paralysis,” said neurosurgeon Barth Green, M.D., Co-Founder and Chairman of The Miami Project, and Professor and Chair of Neurological Surgery. “The Miami Project team includes hundreds of scientists, clinicians, and technicians who have joined hands to make the ‘impossible possible,’ for which this trial is a key goal and dream now being realized. This achievement reaffirms that the tens of millions of dollars and the incalculable work hours were well invested in this first of a kind human Schwann cell project.”
Read full story
Read full story
Miami Project Doctors Perform First Schwann Cell Transplant for Spinal Cord Injury
Doctors performed the first-ever FDA approved Schwann cell transplantation in a patient with a new spinal cord injury
Wednesday - September 4, 2013
Gail F. Beach Memorial Visiting Lectureship Series12pm
LPLC 7th Floor Apex Auditorium
Jonah R. Chan, PhD
Assistant Professor Director of Biochemistryand Molecular BiologyZilkha Neurogenetic Institute Keck School of Medicine
The Project, published bi-annually is the official magazine of The Miami Project and The Buoniconti Fund and is available electronically. Our Annual Research Review summarizes a selection of research publications from the past year.